Evoke Pharma Inc
SEC CIK 1403708 · EVOK · last insider filing 2025-12-19
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Garner CAM L | Director | filed 2013 - 2025 |
| Widder Kenneth J | Director | filed 2013 - 2025 |
| Reed Vickie S | Director | filed 2021 - 2025 |
| D'Onofrio Matthew J | Director · President & Chief Op. Officer | filed 2013 - 2025 |
| Hill Malcolm R | Director | filed 2013 - 2025 |
| Brady Todd C | Director | filed 2013 - 2025 |
| Smeal Benjamin C. | Director | filed 2024 - 2025 |
| Pyszczymuka Greg | Director | filed 2025 - 2025 |
| Gonyer David A | Director · President and CEO | filed 2013 - 2023 |
| Rhoads ANN D | Director | filed 2013 - 2021 |
| Glenn Scott L | Director | filed 2013 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Carlson Marilyn R. | Chief Medical Officer | filed 2013 - 2025 |
| Kowieski Mark | Chief Financial Officer | filed 2024 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.